Early experience using salvage radiotherapy for relapsed/refractory non-Hodgkin lymphomas after CD19 chimeric antigen receptor (CAR) T cell therapy
Brandon S. Imber, Michel Sadelain, Carl DeSelm, Connie Batlevi, Renier J. Brentjens, Parastoo B. Dahi, Sergio Giralt, Jae H. Park, Craig Sauter, Michael Scordo, Gunjan Shah, Miguel Angel Perales, M. Lia Palomba, Joachim Yahalom
Dive into the research topics of 'Early experience using salvage radiotherapy for relapsed/refractory non-Hodgkin lymphomas after CD19 chimeric antigen receptor (CAR) T cell therapy'. Together they form a unique fingerprint.